期刊文献+

补肾化浊胶囊制剂治疗糖尿病肾病98例临床观察

Treatment of Diabetic Nephropathy with Bushen Huazhuo Capsule:A Clinical Report of 98 Cases
下载PDF
导出
摘要 目的观察补肾化浊胶囊对糖尿病肾病的治疗作用。方法将162例糖尿病肾病患者随机分为两组,两组均给予控制饮食、控制血糖、控制血压等常规治疗,对照组给予洛汀新口服,治疗组给予补肾化浊胶囊口服制剂,连用3个月,比较两组治疗前后的中医症候积分、尿蛋白、血脂、血清一氧化氮(NO)、血清C-反应蛋白(CRP)的变化。结果两组治疗后中医症状积分变化比较,差异有统计学意义(P<0.05);治疗后,两组尿白蛋白排泄率、24h尿蛋白定量均减少,差异无统计学意义(P>0.05);治疗组血清胆固醇(TC)、三酰甘油(TG)及CRP水平降低,NO水平升高,与治疗前比较均有统计学意义(P<0.05),两组治疗后的TC、TG、CRP、NO水平比较有统计学意义(P<0.05);两组临床疗效比较差异无统计学意义(P>0.05)。结论补肾化浊胶囊可改善糖尿病肾病的临床症状,通过降低尿蛋白、抑制肾脏内炎症反应、升高血清NO、改善脂代谢异常实现对肾脏的保护作用。 Objective To observe the clinical efficacy of Bushen Huazhuo Capsule for the patients with diabetic nephropathy.Methods Totally 162 patients with diabetic nephropathy were divided as control group and trial group.All the patients were given conventional treatments of controlling diet,blood sugar and blood pressure.The patients in the control group were orally given Lotesin,while the patients in the trial group were given Bushen Huazhuo Capsule for 3 months.Then a comparison was conducted between the two groups on the Chinese medicine symptom integral,and the changes of urine protein,lipids,serum nitric oxide(NO),and serum C-reactive protein(CRP).Results After treatment,the difference in Chinese medicine symptom integral between the two groups was statistically significant(P0.05).But there was no significant difference between the two groups in excretion rate of urine protein and 24h urine protein(P0.05).The levels of total cholesterol(TC),triglyceride(TG) and CRP decreased,and the NO level increased(P0.05).The levels of TC,TG,CRP,and NO after treatment between the two groups showed significant difference(P0.05),but the clinical effects showed no significant difference(P0.05).Conclusion Bushen Huazhuo capsule can improve the clinical symptoms of diabetic nephropathy to protect the kidney by lowering urine protein,controlling inflammation reaction of the kidney,raising serum NO and improving metabolic disorder of blood-lipid.
出处 《临床合理用药杂志》 2011年第02X期66-68,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 糖尿病肾病 补肾化浊胶囊 C-反应蛋白 肾功能 Diabetic nephropathies Bushen huazhuo capsule C-reactive protein Renal function
  • 相关文献

参考文献7

二级参考文献45

  • 1耿嘉,王丹,朴胜华,栗德林.栗德林教授辨治糖尿病肾病的学术思想简介[J].中国中西医结合肾病杂志,2005,6(5):253-254. 被引量:19
  • 2贾忠辉,刘志红,郑敬民,曾彩虹,黎磊石.大黄酸和苯那普利联合治疗db/db糖尿病小鼠的疗效观察[J].肾脏病与透析肾移植杂志,2006,15(2):112-119. 被引量:16
  • 3陈文卫,周立明,郝力丹,孙有刚,毕惠敏.糖尿病肾病肾实质改变与彩色多普勒血流指数间关系探讨[J].中国医学影像技术,1997,13(3):241-242. 被引量:8
  • 4沈稚丹,吴松华,邵福源,等主编.糖尿病慢性并发症.第1版.上海:上海医科大学出版社,1999.164.
  • 5Ishimura E, Nishizawa Y, Kawagishi T, et al. Intarenal hemodynamic abnormalitied in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int, 1997,51 : 1920-1957.
  • 6Kim SH , Kim SM, Lee HK , et al . Diabtic nephropathy: dupl. ex Doppler ultrasound finding. Diabetes Res Clin Pract, 1992,18:75.
  • 7Weidner KM,Arakaki N,Hartmann G,et al.Evidence for the ident ity of human scatterfactor and human hepatocyte growth factor.Proc Natl Acad,Sc i USA,1991,88:7001-7005.
  • 8Montesano R,Matsumoto K,Nakamura T,et al.Identification of a fibroblast -derivedepithelial morphogen as hepatocyte growth factor.Cell,1991,676:901-908.
  • 9Kawaida K,Ohnishi H,Muto Y,et al.Hepatocyte growth factor prevents acut e renalfailure and accelerates renal regeneration in mice.Pro.Natl.Acad.Sci.USA,1994,91:4357-4361.
  • 10Miller SB,Martin DR,Kissane J,et al.Hepatocyte growth factor accelerate s recoveryform acute ischemic renal injury in rats.Am.J.Physiol,1994,266:129-1 34.

共引文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部